# Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

> **NCT04099563** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 13 (actual)

## Conditions studied

- HEALTHY

## Interventions

- **DRUG:** PF-04965842

## Key facts

- **NCT ID:** NCT04099563
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2019-11-09
- **Final completion:** 2019-12-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04099563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04099563, "Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04099563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*